Cargando…

Viral glycoprotein metabolism as a target for antiviral substances

Detalles Bibliográficos
Autores principales:	Klenk, Hans-Dieter, Schwarz, Ralph T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 1982
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134050/ https://www.ncbi.nlm.nih.gov/pubmed/6184015 http://dx.doi.org/10.1016/0166-3542(82)90041-9

Ejemplares similares

Proteolytic Processing of Filovirus Glycoproteins
por: Volchkov, Viktor, et al.
Publicado: (2018)

Coronavirus glycoprotein E1, a new type of viral glycoprotein()
por: Niemann, H., et al.
Publicado: (1981)

Significance of viral glycoproteins for infectivity and pathogenicity()
por: Rott, R., et al.
Publicado: (1987)

Structure and Function of the Hef Glycoprotein of Influenza C Virus
por: Herrler, Georg, et al.
Publicado: (1991)

Targeting of viral glycoproteins to the Golgi complex
por: Hobman, Tom C.
Publicado: (1993)

Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
por: Balzarini, Jan
Publicado: (2007)

Inhibition of Lassa Virus Glycoprotein Cleavage and Multicycle Replication by Site 1 Protease-Adapted α(1)-Antitrypsin Variants
por: Maisa, Anna, et al.
Publicado: (2009)

Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins
por: Tripp, Ralph A., et al.
Publicado: (2021)

Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance
por: Bai, Yaqin, et al.
Publicado: (2021)

A single point mutation of the influenza C virus glycoprotein (HEF) changes the viral receptor-binding activity
por: Szepanski, Sigrun, et al.
Publicado: (1992)

New low-viscosity overlay medium for viral plaque assays
por: Matrosovich, Mikhail, et al.
Publicado: (2006)

Viral and cellular RNA helicases as antiviral targets
por: Kwong, Ann D., et al.
Publicado: (2005)

Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
por: Ilinykh, Philipp A., et al.
Publicado: (2018)

Progression of Antiviral Agents Targeting Viral Polymerases
por: Peng, Siqi, et al.
Publicado: (2022)

Dissecting glycoprotein biosynthesis by the use of specific inhibitors()
por: McDowell, William, et al.
Publicado: (1988)

Expression of Ebolavirus glycoprotein on the target cells enhances viral entry
por: Manicassamy, Balaji, et al.
Publicado: (2009)

Viral recognition and the antiviral interferon response
por: Dalskov, Louise, et al.
Publicado: (2023)

The viral RNA capping machinery as a target for antiviral drugs
por: Ferron, François, et al.
Publicado: (2012)

Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy
por: Idris, Fakhriedzwan, et al.
Publicado: (2016)

Mechanism of Viral Glycoprotein Targeting by Membrane-associated-RING-CH Proteins
por: Lun, Cheng Man, et al.
Publicado: (2021)

A critical review on antiviral peptides derived from viral glycoproteins and host receptors to decoy herpes simplex virus
por: Rahangdale, Rakesh, et al.
Publicado: (2023)

Mechanism of Viral Glycoprotein Targeting by Membrane-Associated RING-CH Proteins
por: Lun, Cheng Man, et al.
Publicado: (2021)

Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein
por: Yi, Dongrong, et al.
Publicado: (2022)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
por: Mazzon, Michela, et al.
Publicado: (2019)

Targeting viral entry as a strategy for broad-spectrum antivirals
por: Mazzon, Michela, et al.
Publicado: (2019)

A Novel Approach of Antiviral Drugs Targeting Viral Genomes
por: Hoang, Phuong Thi, et al.
Publicado: (2022)

MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins
por: Zhang, Yanzhao, et al.
Publicado: (2022)

The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy
por: Santopolo, Silvia, et al.
Publicado: (2021)

Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system
por: Bukreyev, Alexander, et al.
Publicado: (2023)

Extracellular Polymeric Substances: Still Promising Antivirals
por: Bello-Morales, Raquel, et al.
Publicado: (2022)

The roles of ebolavirus glycoproteins in viral pathogenesis
por: Ning, Yun-Jia, et al.
Publicado: (2016)

Viral Vaccines and Antiviral Therapy
por: Tselis, A., et al.
Publicado: (2014)

Viral Vaccines and Antiviral Therapy
por: Tselis, Alex, et al.
Publicado: (2003)

A Potent, Broad-Spectrum Antiviral Agent that Targets Viral Membranes
por: Wojcechowskyj, Jason A., et al.
Publicado: (2010)

Modulation of host metabolism as a target of new antivirals()
por: Ikeda, Masanori, et al.
Publicado: (2007)

Tunicamycin resistant glycosylation of a coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein
por: Holmes, Kathryn V., et al.
Publicado: (1981)

Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses
por: Smith, Wendell, et al.
Publicado: (2013)

In Silico Structure-Based Design of Antiviral Peptides Targeting the Severe Fever with Thrombocytopenia Syndrome Virus Glycoprotein Gn
por: Yuan, Shuo-Feng, et al.
Publicado: (2021)

Ebola sGP—The first viral glycoprotein shown to be C-mannosylated
por: Falzarano, Darryl, et al.
Publicado: (2007)

TRANSPORT OF VIRAL GLYCOPROTEINS AND ITS MODULATION BY MONENSIN
por: Alonso-Caplen, Firelli V., et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_62kpuqgsib86vvsahmf06efuvs